Stay updated on Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial
Sign up to get notified when there's something new on the Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial page.

Latest updates to the Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new revision entry v3.6.6 was added to the study record history and the previous v3.6.5 entry was removed, updating the historical record to reflect the latest published version.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedA new revision entry v3.6.5 was added to the study record history, superseding the previous v3.6.4.SummaryDifference0.1%

- Check51 days agoChange DetectedRecord history includes a new revision entry v3.6.4, superseding v3.6.3. This reflects a minor metadata update to the page rather than changes to study data or content.SummaryDifference0.1%

- Check73 days agoChange DetectedThe record history now includes revision v3.6.3, replacing the previous v3.6.2. This indicates a minor update to the study record's metadata.SummaryDifference0.1%

- Check80 days agoChange DetectedThe record history now includes a new revision entry v3.6.2. The previous revision v3.6.0 was removed.SummaryDifference0.1%

- Check94 days agoChange DetectedRecruitment for the study is no longer open, and the history now reflects a new revision (v3.6.0) replacing the previous one (v3.5.5).SummaryDifference0.5%

Stay in the know with updates to Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial page.